CARsgen Therapeutics Holdings Ltd
HKEX:2171

Watchlist Manager
CARsgen Therapeutics Holdings Ltd Logo
CARsgen Therapeutics Holdings Ltd
HKEX:2171
Watchlist
Price: 15.03 HKD 1.49%
Market Cap: 8.7B HKD

Operating Margin
CARsgen Therapeutics Holdings Ltd

-671.7%
Current
-2 366%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-671.7%
=
Operating Profit
-564.6m
/
Revenue
84m

Operating Margin Across Competitors

No Stocks Found

CARsgen Therapeutics Holdings Ltd
Glance View

Market Cap
8.7B HKD
Industry
Biotechnology

CARsgen Therapeutics Holdings Ltd. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of CAR-T cell therapies. The company is headquartered in Shanghai, Shanghai and currently employs 573 full-time employees. The company went IPO on 2021-06-18. The Company’s therapies are applied in the treatment of hematological malignancies and solid tumors. The firm have developed an upgraded B cell maturation antigen (BCMA) targeted CAR-T product, CT053, which is its sole core product candidate. The firm conducts its businesses in China and the United States.

Intrinsic Value
10.96 HKD
Overvaluation 27%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-671.7%
=
Operating Profit
-564.6m
/
Revenue
84m
What is the Operating Margin of CARsgen Therapeutics Holdings Ltd?

Based on CARsgen Therapeutics Holdings Ltd's most recent financial statements, the company has Operating Margin of -671.7%.

Back to Top